Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Vortioxetine Hydrobromide Tablets

Approval Number

国药准字HJ20170382

CompanyH. Lundbeck A/S

Registration Date

July 29, 2022

Previous Approval Numbers

H20170382

Drug Information

Generic Name

氢溴酸伏硫西汀片

Trade Name

心达悦

Dosage Form

片剂

Strength

5mg(以C₁₈H₂₂N₂S计)

Drug Type

化学药品

Registration Date

July 29, 2022

Expiry Date

July 28, 2027

Company Information

Applicant Company

Company NameH. Lundbeck A/S

Company Address

Ottiliavej 9, 2500 Valby, Denmark

Manufacturing Company

Company NameH. Lundbeck A/S

Company Address

Ottiliavej 9, 2500 Valby, Denmark

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy